Connect with us

News

FDA advisory panel rejects widespread Pfizer booster shots

Published

on

FDA advisory panel rejects widespread Pfizer booster shots

WASHINGTON (AP) — An influential federal advisory panel has soundly rejected a plan to offer Pfizer booster shots against COVID-19 to most Americans.

The vote Friday, 16-2, was a blow to the Biden administration’s effort to shore up people’s protection against the virus amid the highly contagious delta variant.

Over several hours of discussion, members of the Food and Drug Administration panel of outside experts voiced frustration that Pfizer had provided little data on the safety of extra doses.

And they complained that data provided by Israeli researchers about their booster campaign might not be suitable for predicting the U.S. experience.

More from NEWS10

  • Pentagon reverses itself, calls deadly Kabul drone strike an error
  • Albany County coronavirus update, September 18
  • 9/18/2021: One last cloudy, humid day
  • Brian Laundrie missing as search for his fiancé Gabby Petito continues
  • Shenendehowa defense brings the juice in revenge win over Guilderland

Follow NEWS10

Sign-up for our Newsletter

google news